Clinical Trial Update: FREEZE-AFIB Post-Market Study

View source ↗

Summary

Post-market study update for AtriCure's FREEZE-AFIB device in atrial fibrillation and atrial flutter; trial has completed with results posted on 2025-01-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• FREEZE-AFIB

Snippet

Sponsor: AtriCure, Inc. | Conditions: Atrial Fibrillation, Atrial Flutter | Status: COMPLETED | Results posted: 2025-01-13